Mark B. Medley - May 11, 2021 Form 3 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Role: Regional President
Signature: Christopher G. Cobb, Attorney in Fact for Mark B Medley
Stock symbol: CYH
Transactions as of: May 11, 2021
Transactions value $: $0
Form type: 3
Date filed: 5/20/2021, 04:23 PM
Next filing: Jun 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CYH	Common Stock						39.8K	May 11, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CYH	Performance Based Restricted							May 11, 2021	Common Stock	15K	$0.00	Direct	F1
holding	CYH	Performance Based Restricted							May 11, 2021	Common Stock	15K	$0.00	Direct	F2
holding	CYH	Stock Options (Right to Buy)							May 11, 2021	Common Stock	12K	$2.66	Direct	F3
holding	CYH	Stock Options (Right to Buy)							May 11, 2021	Common Stock	15K	$4.93	Direct	F3
holding	CYH	Stock Options (Right to Buy)							May 11, 2021	Common Stock	15K	$8.81	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant (3/1/2020), subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.
F2	The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant (3/1/2021), subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
F3	Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.